Potent and orally bioavailable noncysteine-containing inhibitors of protein farnesyltransferase (Q77751689)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10328287%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Potent and orally bioavailable noncysteine-containing inhibitors of protein farnesyltransferase (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10328287%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

D J Augeri

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10328287%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

D Janowick

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10328287%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

D Kalvin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10328287%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

G Sullivan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10328287%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

J Larsen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10328287%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

D Dickman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10328287%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

H Ding

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10328287%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

J Cohen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10328287%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

J Lee

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10328287%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

R Warner

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10328287%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

P Kovar

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10328287%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

S Cherian

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10328287%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

B Saeed

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10328287%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

H Zhang

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10328287%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

S Tahir

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10328287%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

S C Ng

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10328287%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

H Sham

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10328287%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

S H Rosenberg

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10328287%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 April 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10328287%20AND%20SRC:MED&resulttype=core&format=json

Bioorganic & Medicinal Chemistry Letters

8 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10328287%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10328287%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10328287%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

1069-1074

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10328287%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900144-4

7 January 2021

Protein prenylation: more than just glue?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900144-4

7 January 2021

All ras proteins are polyisoprenylated but only some are palmitoylated

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900144-4

7 January 2021

Protein prenylation: genes, enzymes, targets, and functions.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900144-4

7 January 2021

Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900144-4

7 January 2021

The potential of farnesyltransferase inhibitors as cancer chemotherapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900144-4

7 January 2021

CA1A2X-competitive inhibitors of farnesyltransferase as anti-cancer agents

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900144-4

7 January 2021

Ras farnesyltransferase: a new therapeutic target

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900144-4

7 January 2021

Inhibitors of farnesyl protein transferase. 4-Amido, 4-carbamoyl, and 4-carboxamido derivatives of 1-(8-chloro-6,11-dihydro-5H-benzo[5,6]- cyclohepta[1,2-b]pyridin-11-yl)piperazine and 1-(3-bromo-8-chloro-6,11- dihydro-5H-benzo[5,6]cyclohepta[1,2-b]

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900144-4

7 January 2021

Structure-activity relationship of 3-substituted N-(pyridinylacetyl)-4- (8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene )- piperidine inhibitors of farnesyl-protein transferase: design and synthesis of in vivo active antitumo

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900144-4

7 January 2021

Development of highly potent inhibitors of Ras farnesyltransferase possessing cellular and in vivo activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900144-4

7 January 2021

Benzodiazepine peptidomimetics: potent inhibitors of Ras farnesylation in animal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900144-4

7 January 2021

Potent, cell active, non-thiol tetrapeptide inhibitors of farnesyltransferase.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900144-4

7 January 2021

Pseudopeptide inhibitors of Ras farnesyl-protein transferase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900144-4

7 January 2021

Pseudodipeptide inhibitors of protein farnesyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900144-4

7 January 2021

Novel conformationally extended naphthalene-based inhibitors of farnesyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900144-4

7 January 2021

Design and synthesis of non-peptide Ras CAAX mimetics as potent farnesyltransferase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900144-4

7 January 2021

Potent and selective non-cysteine-containing inhibitors of protein farnesyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900144-4

7 January 2021

10.1016/S0960-894X(99)00144-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10328287%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference